TipRanks
Go Ultimate55% OFF

China Resources Pharmaceutical Group Ltd. (640) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

640 Analyst Ratings

Strong Buy
5Ratings
5Buy0Hold0Sell
Based on 5 analysts giving stock ratings to China Resources Pharmaceutical Group Ltd. in the past 3 months

640 Stock 12 Month Forecast

EUR 0.74▲(44.44% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for China Resources Pharmaceutical Group Ltd. in the last 3 months. The average price target is EUR 0.74 with a high forecast of EUR 0.82 and a low forecast of EUR 0.65. The average price target represents a 44.44% change from the last price of EUR 0.52.
Highest Price TargetEUR 0.82Average Price TargetEUR 0.74Lowest Price TargetEUR 0.65

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:640
Price TargetFollowArticle
CICC Analyst forecast on DE:640Unknown AnalystNot RankedCICCEUR 0.80buy54.60%UpsideReiterated08/26/26
Morgan Stanley Analyst forecast on DE:640Unknown AnalystNot RankedMorgan StanleyEUR 0.82buy59.02%UpsideReiterated08/26/26
CLSA Analyst forecast on DE:640Unknown AnalystNot RankedCLSAEUR 0.74buy43.56%UpsideReiterated08/26/26
China Merchants Securities Analyst forecast on DE:640Unknown AnalystNot RankedChina Merchants SecuritiesEUR 0.72buy39.14%UpsideReiterated08/26/26
Bank of America Securities Analyst forecast on DE:640Unknown AnalystNot RankedBank of America SecuritiesEUR 0.65buy25.89%UpsideReiterated08/25/26
Guotai Haitong Analyst forecast on DE:640Unknown AnalystNot RankedGuotai HaitongEUR 0.78buy50.63%UpsideReiterated04/20/26
Nomura Analyst forecast on DE:640Unknown AnalystNot RankedNomuraEUR 0.86buy66.09%UpsideReiterated03/26/26
UBS Analyst forecast on DE:640Unknown AnalystNot RankedUBSEUR 0.78buy52.39%UpsideReiterated03/25/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering China Resources Pharmaceutical Group Ltd.

3 Months
Google Health Care EU
Google Health Care EUTipRanks - Google
Success Rate1/1 ratings generated profit
100%
Average Return
+2.90%

Copying Google Health Care EU's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +2.90% per trade.

1 Year
Google Health Care EU
Google Health Care EUTipRanks - Google
Success Rate1/1 ratings generated profit
100%
Average Return
+6.80%

Copying Google Health Care EU's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.80% per trade.

2 Years
Google Health Care EU
Google Health Care EUTipRanks - Google
Success Rate1/1 ratings generated profit
100%
Average Return
+6.80%

Copying Google Health Care EU's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +6.80% per trade.

640 Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 640
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy03330
Buy02220
Hold00000
Sell00000
Strong Sell00000
total05550

In the current month, 640 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 640 average Analyst price target in the past 3 months is 0.74.

640 Financial Forecast

640 Stock Forecast FAQ

What is DE:640’s average 12-month price target, according to analysts?
Based on analyst ratings, China Resources Pharmaceutical Group Ltd.’s 12-month average price target is €0.74.
What is DE:640’s upside potential, based on the analysts’ average price target?
China Resources Pharmaceutical Group Ltd. has 44.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is China Resources Pharmaceutical Group Ltd. a Buy, Sell or Hold?
China Resources Pharmaceutical Group Ltd. has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is China Resources Pharmaceutical Group Ltd.’s share price target?
The average share price target for China Resources Pharmaceutical Group Ltd. is €0.74. This is based on 5 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €0.82, and the lowest forecast is €0.65. The average share price target represents a 44.44% increase from the current price of €0.515.
What do analysts say about China Resources Pharmaceutical Group Ltd.?
China Resources Pharmaceutical Group Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of China Resources Pharmaceutical Group Ltd.?
To buy shares of DE:640, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.